CheckMan Stock Market Overview
Trending Stocks
Red List
In Today's Headlines

Tesla (NASDAQ:TSLA | TSLA Price Prediction) stock is down 3% in Friday afternoon trading, with shares sliding from an opening price of $372.11 to around $361.

Cheniere Energy's Train 5 at its Corpus Christi liquefied natural gas expansion project is now operating at full capacity, the company said on Friday.

A Utah-based defense technology company, Red Cat Holdings (NASDAQ:RCAT) reported record Q4 2025 revenue of $26.2 million on March 18, then watched shares fall nearly 17% in the days after.

SAN FRANCISCO, March 27, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman notifies investors of the filing of a securities class action against Apollo Global Management, Inc. (NYSE: APO) following a series of investigative reports. The litigation seeks to represent investors who purchased or otherwise acquired Apollo securities between May 10, 2021, and February 21, 2026 (the “Class Period”).

SAN FRANCISCO, March 27, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) that the deadline to move for Lead Plaintiff in the pending securities class action is April 21, 2026. The firm urges Corcept investors who suffered significant losses to contact the firm now to discuss their rights.

Autolus Therapeutics plc (AUTL) Q4 2025 Earnings Call Transcript

Iconic Fendt® golden tractor shines at White House event and celebrates farmers who feed the world. WASHINGTON, March 27, 2026 /PRNewswire/ -- AGCO (NYSE: AGCO) senior leaders joined President Donald Trump, farmers, industry representatives and policymakers at the White House in Washington, D.C.

SAN DIEGO, March 27, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product.

SAN FRANCISCO, March 27, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is notifying investors that a securities class action lawsuit has been filed against Zynex, Inc. (ZYXI/ ZYXIQ) and its former top executives. The litigation follows the company's delisting and subsequent Chapter 11 bankruptcy filing triggered by revelations of a massive overbilling scheme.

LOS ANGELES, March 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ImmunityBio, Inc., (“Super Micro” or the "Company") (NASDAQ: IBRX) investors of a class action on behalf of investors that bought securities between January 19, 2026 and March 24, 2026, inclusive (the “Class Period”). Immunity Bio investors have until May 26, 2026 to file a lead plaintiff motion.
